About: OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.15 (-0.86%)
OSTX NYSE OS Therapies Incorporated
OS Therapies Incorporated share price
Atividade de preço de OSTX
Último preço
$ 1,170
Variação (24h)
0,01 USD (0,86%)
Volume
503.31K
Volume (média 4 sem.)
-
Abertura
$ 1,18
Variação do dia
$ 1,11 - $ 1,21
Fechamento anterior
$ 1,16
Último negócio
04 Nov, 9:00 pm GMT+0
Atrasado
04 Nov, 9:00 pm GMT+0
OSTX price performance
Atrasado
04 Nov, 9:00 pm GMT+0
OSTX details
quote.marketSignals